These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11269459)

  • 21. Cognitive outcomes three years after coronary artery bypass surgery: a comparison of on-pump coronary artery bypass graft surgery and nonsurgical controls.
    Selnes OA; Grega MA; Borowicz LM; Barry S; Zeger S; Baumgartner WA; McKhann GM
    Ann Thorac Surg; 2005 Apr; 79(4):1201-9. PubMed ID: 15797050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between testosterone and apolipoprotein E epsilon4 status on cognition in healthy older men.
    Burkhardt MS; Foster JK; Clarnette RM; Chubb SA; Bruce DG; Drummond PD; Martins RN; Yeap BB
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1168-72. PubMed ID: 16368754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lower cognitive performance of older football players possessing apolipoprotein E epsilon4.
    Kutner KC; Erlanger DM; Tsai J; Jordan B; Relkin NR
    Neurosurgery; 2000 Sep; 47(3):651-7; discussion 657-8. PubMed ID: 10981753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery.
    Newman MF; Kirchner JL; Phillips-Bute B; Gaver V; Grocott H; Jones RH; Mark DB; Reves JG; Blumenthal JA;
    N Engl J Med; 2001 Feb; 344(6):395-402. PubMed ID: 11172175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive changes with coronary artery disease: a prospective study of coronary artery bypass graft patients and nonsurgical controls.
    Selnes OA; Grega MA; Borowicz LM; Royall RM; McKhann GM; Baumgartner WA
    Ann Thorac Surg; 2003 May; 75(5):1377-84; discussion 1384-6. PubMed ID: 12735550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postoperative cognitive change after cardiac surgery predicts long-term cognitive outcome.
    Relander K; Hietanen M; Rantanen K; Rämö J; Vento A; Saastamoinen KP; Roine RO; Soinne L
    Brain Behav; 2020 Sep; 10(9):e01750. PubMed ID: 32681544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary artery bypass grafting with single cross-clamp results in fewer persistent neuropsychological deficits than multiple clamp or off-pump coronary artery bypass grafting.
    Hammon JW; Stump DA; Butterworth JF; Moody DM; Rorie K; Deal DD; Kincaid EH; Oaks TE; Kon ND
    Ann Thorac Surg; 2007 Oct; 84(4):1174-8; discussion 1178-9. PubMed ID: 17888966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
    Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
    Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A dynamic view of depressive symptoms and neurocognitive change among patients with coronary artery disease.
    Freiheit EA; Hogan DB; Eliasziw M; Patten SB; Demchuk AM; Faris P; Anderson T; Galbraith D; Parboosingh JS; Ghali WA; Knudtson M; Maxwell CJ
    Arch Gen Psychiatry; 2012 Mar; 69(3):244-55. PubMed ID: 22393217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
    Qiu C; Winblad B; Fratiglioni L
    Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive outcomes three years after coronary artery bypass surgery: relation to diffusion-weighted magnetic resonance imaging.
    Knipp SC; Matatko N; Wilhelm H; Schlamann M; Thielmann M; Lösch C; Diener HC; Jakob H
    Ann Thorac Surg; 2008 Mar; 85(3):872-9. PubMed ID: 18291160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurocognitive dysfunction after coronary artery bypass surgery: a systematic review.
    van Dijk D; Keizer AM; Diephuis JC; Durand C; Vos LJ; Hijman R
    J Thorac Cardiovasc Surg; 2000 Oct; 120(4):632-9. PubMed ID: 11003741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depression and cognitive decline after coronary artery bypass grafting.
    McKhann GM; Borowicz LM; Goldsborough MA; Enger C; Selnes OA
    Lancet; 1997 May; 349(9061):1282-4. PubMed ID: 9142062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein E genotype and lifetime cognitive decline.
    Kozauer NA; Mielke MM; Chan GK; Rebok GW; Lyketsos CG
    Int Psychogeriatr; 2008 Feb; 20(1):109-23. PubMed ID: 17711604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychological functioning 3-5 years after coronary artery bypass grafting: does the pump make a difference?
    Stroobant N; van Nooten G; De Bacquer D; Van Belleghem Y; Vingerhoets G
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):396-401. PubMed ID: 18524617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive outcomes in elderly high-risk patients after off-pump versus conventional coronary artery bypass grafting: a randomized trial.
    Jensen BO; Hughes P; Rasmussen LS; Pedersen PU; Steinbrüchel DA
    Circulation; 2006 Jun; 113(24):2790-5. PubMed ID: 16769915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between ApoE epsilon4 and cognitive impairment after stroke.
    Wagle J; Farner L; Flekkøy K; Wyller TB; Sandvik L; Eiklid KL; Fure B; Stensrød B; Engedal K
    Dement Geriatr Cogn Disord; 2009; 27(6):525-33. PubMed ID: 19494491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurocognitive deficit following coronary artery bypass grafting: a prospective study of surgical patients and nonsurgical controls.
    Zimpfer D; Czerny M; Vogt F; Schuch P; Kramer L; Wolner E; Grimm M
    Ann Thorac Surg; 2004 Aug; 78(2):513-8; discussion 518-9. PubMed ID: 15276509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
    Martins CA; Oulhaj A; de Jager CA; Williams JH
    Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.